The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Individualized treatment with sunitinib versus standard dosing with sunitinib or pazopanib in patients with metastatic renal cell carcinoma (mRCC): Results from the Canadian Kidney Cancer information system (CKCis).
 
Naveen S. Basappa
Honoraria - Astellas Oncology; Janssen; Novartis; Pfizer
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Janssen; Novartis; Pfizer
Research Funding - Agensys (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Janssen; Novartis
 
Aly-Khan A. Lalani
No Relationships to Disclose
 
Haocheng Li
No Relationships to Disclose
 
Austin Kalirai
No Relationships to Disclose
 
Lori Wood
Research Funding - Bristol-Myers Squibb (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); Pfizer (Inst); Roche Canada (Inst)
Travel, Accommodations, Expenses - Novartis
 
Christian K. Kollmannsberger
Honoraria - Bristol-Myers Squibb; Novartis; Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis; Pfizer; Seagen
 
Hao-Wen Sim
Travel, Accommodations, Expenses - Roche
 
Anil Kapoor
Speakers' Bureau - Novartis; Pfizer
Research Funding - Novartis; Pfizer
 
Sebastien J. Hotte
Honoraria - Astellas Scientific and Medical Affairs Inc; Janssen Oncology; Sanofi
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Janssen; Pfizer
Research Funding - Agensys; AstraZeneca; Bayer; Boehringer Ingelheim; Novartis; Oncogenex; Roche/Genentech; Sanofi
 
Piotr Czaykowski
Research Funding - Argos Therapeutics (Inst); Exelixis (Inst); Merck (Inst)
 
Christina M. Canil
Honoraria - Astellas Pharma; Bayer; Janssen
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Pfizer; Roche; Sanofi
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Janssen (Inst); Roche (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Pfizer
 
M. Neil Reaume
Honoraria - Ferring; Merck; Novartis; Sanofi
Consulting or Advisory Role - Astellas Pharma; Bayer; Janssen; Pfizer; Roche
 
Georg A. Bjarnason
Honoraria - Bristol-Myers Squibb; Novartis; Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis; Pfizer
Research Funding - Pfizer (Inst)
Travel, Accommodations, Expenses - Novartis; Pfizer
 
Marie Vanhuyse
Consulting or Advisory Role - Astellas Pharma; Bayer Schering Pharma; Bristol-Myers Squibb; Johnson & Johnson; Pfizer; Sanofi
Research Funding - sanofi (Inst)
 
Denis Soulieres
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis; Pfizer
 
Eric Levesque
No Relationships to Disclose
 
Scott A. North
Honoraria - Astellas Pharma; Janssen-Ortho; Novartis; Pfizer; Sanofi
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Janssen Oncology; Merck; Novartis; Pfizer; Roche Canada; Sanofi
 
Daniel Yick Chin Heng
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Janssen; Novartis; Pfizer